ADA InVivo

About ADA InVivo

ADA InVivo B.V. offers a new technology for predicting human patients’ immune responses to protein-based therapeutic drugs: In vivo immunogenicity testing using genetically modified mice. Predicting immunogenicity in an early stage of protein drug development can save the pharmaceutical industry large amounts of investment dollars and reduce time-to-market of new medicines. Additionally, ADA InVivo B.V. leverages its quality control expertise (GLP, ISO) by offering Quality Management Control, Auditing & Certification services across a range of industries, including Medical and Automotive.

Address

• Headquarters

  Singel 5401017AZ AmsterdamNoord-Holland, Netherlands

Team by function

Based on 1 public job profiles as of 3 September 2026.

• Founder / Owner1